March 24th 2023
An analysis of perimenopausal women with rheumatoid arthritis indicated that patients receiving exogenous sex hormones more frequently achieved SDAI- and CDAI-defined remission.
March 14th 2023
Exposure to phthalates linked to diabetes in midlife white womenFebruary 9th 2023
Further adding to the discussion surrounding the impact of endocrine-disrupting chemicals, an analysis of data from the SWAN Multipollutant Study suggests increased exposure to phthlates was linked to a 30-63% increase in risk of developing diabetes among White women in midlife.
FDA accepts BLA for Sandoz proposed denosumab biosimilarFebruary 6th 2023
The US Food and Drug Administration has accepted the Biologics License Application (BLA) for a proposed biosimilar of denosumab (Prolia and Xgeva; Amgen) for treatment of various conditions.
Lowers sex hormone levels linked to traumatic experiencesOctober 14th 2022
Traumatic experiences are associated with lower levels of sex hormones in midlife women, especially those with short sleep, according to research presented at the North American Menopause Society Annual Meeting.
Hormone therapy linked to shoulder pain and loss of motion prevention in menopauseOctober 13th 2022
Hormone therapy was linked as a potential preventative treatment for adhesive capsulitis in menopausal women, according to a study presented at the North American Menopause Society Annual Meeting.
Which is worse: Night sweats or hot flashes?October 13th 2022
In a presentation at the North American Menopause Society Annual Meeting, investigators found these signs of menopause are 2 very separate symptoms and have different effects on stress and depression in menopausal women.
New hormone therapy guidelines from the North American Menopause SocietyJuly 22nd 2022
The 2022 position statement confirms hormone therapy as the most effective treatment for vasomotor symptoms in menopause and includes updated guidelines for age- and condition-specific treatment plans.
Hormone shift in menopause contributes to cardiovascular risk in aging womenMay 18th 2022
New research from a team of investigators in Europe suggests hormonal changes during menopause could explain up to 10% of the increase in LDL-C associated with the transition to menopause among aging women
Topical interventions on the vaginal microbiota in postmenopausal womenApril 28th 2022
Vaginal estradiol tablets produced significant changes in vaginal microbiota and metabolome with a lowering pH, especially in women with highly divers bacterial communities at baseline, according to a secondary analysis in JAMA Network Open.
Endometriosis and early natural menopauseApril 13th 2022
Women with laparoscopically confirmed endometriosis are at significantly higher risk for early natural menopause (ENM), and this risk was greater for nulliparous women and women who never reported using oral contraceptives, according to a study in JAMA Network Open.
Anti-mullerian hormone premenopause can predict bone loss risk later in lifeApril 8th 2022
New research from the University of California Los Angeles (UCLA) suggests assessments of anti-Mullerian hormone levels could help clinicians predict or detect bone loss among premenopausal women.
Sleep apnea may worsen joint pain, fatigue in postmenopausal womenMarch 25th 2022
A study published in Menopause, the journal of the North American Menopause Society (NAMS), investigated the association between sleep apnea and the various physical and psychological symptoms that occur during menopause.
Fezolinetant demonstrates topline results in long-term phase 3 study for VMSMarch 11th 2022
Astellas announced positive data from its study investigating the long-term safety of fezolinetant for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause.